Euroespes S.A. (EEP) - Cash Flow Conversion Efficiency

Latest as of December 2022: 0.003x

Based on the latest financial reports, Euroespes S.A. (EEP) has a cash flow conversion efficiency ratio of 0.003x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€16.87K ≈ $19.72K USD) by net assets (€6.20 Million ≈ $7.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Euroespes S.A. (EEP) defensive interval to measure how many days the company can operate on defensive assets alone.

Euroespes S.A. - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how Euroespes S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Euroespes S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Euroespes S.A. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
iDimension Consolidated Bhd
KLSE:0174
0.001x
SIMFABRIC SA ZY-10
F:853
0.139x
Cooper Metals Ltd
AU:CPM
-0.020x
Mears Group plc
LSE:MER
0.354x
Kane Biotech Inc
V:KNE
0.912x
Indaptus Therapeutics Inc
NASDAQ:INDP
-1.012x
RENFORTH RESS. INC. NEW
F:9RR
0.400x
International Lithium Corp
V:ILC
-0.028x

Annual Cash Flow Conversion Efficiency for Euroespes S.A. (2010–2024)

The table below shows the annual cash flow conversion efficiency of Euroespes S.A. from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Euroespes S.A..

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €2.57 Million
≈ $3.01 Million
€70.53K
≈ $82.45K
0.027x -85.74%
2023-12-31 €2.89 Million
≈ $3.38 Million
€556.08K
≈ $650.12K
0.192x +284.10%
2022-12-31 €6.20 Million
≈ $7.25 Million
€-647.82K
≈ $-757.37K
-0.104x -4775.18%
2021-12-31 €7.43 Million
≈ $8.68 Million
€16.60K
≈ $19.41K
0.002x +105.78%
2020-12-31 €7.44 Million
≈ $8.70 Million
€-287.52K
≈ $-336.15K
-0.039x +43.58%
2019-12-31 €7.45 Million
≈ $8.71 Million
€-510.28K
≈ $-596.57K
-0.068x -1425.55%
2018-12-31 €8.80 Million
≈ $10.29 Million
€45.47K
≈ $53.16K
0.005x -97.41%
2017-12-31 €4.57 Million
≈ $5.34 Million
€911.75K
≈ $1.07 Million
0.200x +88.63%
2016-12-31 €4.26 Million
≈ $4.98 Million
€451.25K
≈ $527.55K
0.106x -21.39%
2015-12-31 €3.08 Million
≈ $3.60 Million
€414.91K
≈ $485.07K
0.135x +302.30%
2014-12-31 €2.75 Million
≈ $3.21 Million
€91.88K
≈ $107.42K
0.033x +45.12%
2010-12-31 €3.98 Million
≈ $4.66 Million
€91.88K
≈ $107.42K
0.023x --

About Euroespes S.A.

MC:EEP Spain Diagnostics & Research
Market Cap
$4.61 Million
€3.95 Million EUR
Market Cap Rank
#28993 Global
#212 in Spain
Share Price
€0.34
Change (1 day)
+0.00%
52-Week Range
€0.34 - €0.34
All Time High
€1.26
About

Euroespes, S.A., a medical center, provides medical services for the research, diagnosis, and treatment of central nervous system disorders and other diseases in Spain and internationally. It offers personalized and genomic medicine services for predictive, diagnostic, and therapeutic purposes. The company also provides medical services, such as neuro-ophthalmology, neuro-otorhinolaryngology, neu… Read more